Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Issues Complete Response Letter to GlaxoSmithKline for Eurand's EUR-1048
FDA Issues Complete Response Letter to GlaxoSmithKline for Eurand's EUR-1048
FDA Issues Complete Response Letter to GlaxoSmithKline for Eurand's EUR-1048
Submitted by
admin
on December 27, 2008 - 11:22am
Source:
GlobeNewsWire
News Tags:
GSK
Aptalis
EUR-1048
Headline:
FDA Issues Complete Response Letter to GlaxoSmithKline for Eurand's EUR-1048
Do Not Allow Advertisers to Use My Personal information
